NEULANDLAB - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

IntraDay Trade Rating: 4.3

💹 Optimal Buy Price: ₹17,550–₹17,600 (slightly below current price and near intraday support)

🎯 Profit Target: ₹17,850–₹18,000 (resistance zone near recent high)

🛡️ Stop Loss: ₹17,400 (below breakout level and psychological support)

📊 Exit Strategy if Already Holding: Consider exiting near ₹17,900 if RSI exceeds 73 and MACD flattens. Watch for price rejection near ₹18,000 and volume divergence.

✅ Positive

• 📈 RSI at 70.2 and MACD at 424 indicate strong bullish momentum
• 📊 Trading well above both 50 DMA (₹15,382) and 200 DMA (₹13,567), confirming strong uptrend
• 📉 Debt-to-equity ratio of 0.10 reflects low financial leverage
• 📈 EPS of ₹136 and strong price action near 52-week high (94.2% index)
• 📊 DII holding increased by 1.98%, showing domestic institutional confidence

⚠️ Limitation

• 📉 Volume today (1.09L) is only moderately above 1-week average (69.8K)
• 📉 High P/E of 174 vs industry average of 33.1 suggests overvaluation
• 📉 PEG ratio of 3.67 indicates expensive growth expectations
• 📉 ROE (14.8%) and ROCE (18.7%) are decent but not exceptional for the valuation
• 📉 FII holding declined by 1.09%

🚫 Company Negative News

• 📉 Quarterly PAT dropped sharply from ₹27.7 Cr to ₹13.7 Cr (QoQ)

📢 Company Positive News

• 📈 Strong EPS and price breakout near 52-week high suggest investor optimism
• 📊 Technical indicators support continued momentum in the short term

🏭 Industry

• 🧪 NEULANDLAB operates in the pharmaceutical and API manufacturing sector, which benefits from global healthcare demand
• 📈 Industry P/E of 33.1 supports long-term valuation potential for quality players

🧾 Conclusion

📌 NEULANDLAB presents a strong intraday setup today with breakout momentum, technical strength, and institutional support. Traders may consider entering near ₹17,575 with a target of ₹17,900 and stop loss at ₹17,400. If already holding, monitor RSI and MACD for exit signals near resistance.

I can also help you compare NEULANDLAB’s setup with other pharma stocks like Divi’s Labs or Laurus Labs to identify sharper intraday opportunities.